Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis

Conclusions:
Comorbidities are associated with treatment decisions regarding DMTs in MS. A better understanding of the effects of comorbidity on effectiveness and safety of DMTs is needed.

Source: Neurology - April 3, 2016 Category: Neurology Authors: Zhang, T., Tremlett, H., Leung, S., Zhu, F., Kingwell, E., Fisk, J. D., Bhan, V., Campbell, T. L., Stadnyk, K., Yu, B. N., Marrie, R. A., For the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis Tags: Multiple sclerosis, Cohort studies ARTICLE Source Type: research